Literature DB >> 20304920

Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Ilse Jongerius1, Brandon L Garcia, Brian V Geisbrecht, Jos A G van Strijp, Suzan H M Rooijakkers.   

Abstract

The human pathogen Staphylococcus aureus secretes several complement evasion molecules to combat the human immune response. Extracellular complement-binding protein (Ecb) binds to the C3d domain of C3 and thereby blocks C3 convertases of the alternative pathway and C5 convertases via all complement pathways. Inhibition of C5 convertases results in complete inhibition of C5a generation and subsequent neutrophil migration. Here, we show that binding of Ecb to the C3d domain of C3b is crucial for inhibition of C5 convertases. Ecb does not interfere with substrate binding to convertases but prevents formation of an active convertase enzyme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304920      PMCID: PMC2865291          DOI: 10.1074/jbc.M109.091975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

3.  Functional role of the noncatalytic subunit of complement C5 convertase.

Authors:  N Rawal; M K Pangburn
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

Review 4.  Structure/function of C5 convertases of complement.

Authors:  N Rawal; M K Pangburn
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

Review 5.  Structure and function of complement C5 convertase enzymes.

Authors:  M K Pangburn; N Rawal
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

6.  Formation of high-affinity C5 convertases of the alternative pathway of complement.

Authors:  N Rawal; M Pangburn
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 7.  What determines nasal carriage of Staphylococcus aureus?

Authors:  S J Peacock; I de Silva; F D Lowy
Journal:  Trends Microbiol       Date:  2001-12       Impact factor: 17.079

8.  Complement C3b interactions studied with surface plasmon resonance technique.

Authors:  T S Jokiranta; J Westin; U R Nilsson; B Nilsson; J Hellwage; S Löfås; D L Gordon; K N Ekdahl; S Meri
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

9.  Functional characterization of the lectin pathway of complement in human serum.

Authors:  Anja Roos; Lee H Bouwman; Jeric Munoz; Tahlita Zuiverloon; Maria C Faber-Krol; Francien C Fallaux-van den Houten; Ngaisah Klar-Mohamad; C Erik Hack; Marcel G Tilanus; Mohamed R Daha
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

10.  Staphylococcal complement evasion by various convertase-blocking molecules.

Authors:  Ilse Jongerius; Jörg Köhl; Manoj K Pandey; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  17 in total

Review 1.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Allosteric inhibition of complement function by a staphylococcal immune evasion protein.

Authors:  Hui Chen; Daniel Ricklin; Michal Hammel; Brandon L Garcia; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; Apostolia Tzekou; Sheng Li; Brian V Geisbrecht; Virgil L Woods; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 3.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.

Authors:  Brandon L Garcia; Brady J Summers; Kasra X Ramyar; Apostolia Tzekou; Zhuoer Lin; Daniel Ricklin; John D Lambris; John H Laity; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

5.  Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.

Authors:  Julia A Sharp; Kenji M Cunnion
Journal:  Mol Immunol       Date:  2010-12-15       Impact factor: 4.407

6.  Mechanisms of Host-Pathogen Protein Complex Formation and Bacterial Immune Evasion of Streptococcus suis Protein Fhb.

Authors:  Xueqin Li; Peng Liu; Shuzhen Gan; Chunmao Zhang; Yuling Zheng; Yongqiang Jiang; Yuan Yuan
Journal:  J Biol Chem       Date:  2016-06-24       Impact factor: 5.157

7.  Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic.

Authors:  Julia A Sharp; Charlene G Echague; Pamela S Hair; Michael D Ward; Julius O Nyalwidhe; Joan A Geoghegan; Timothy J Foster; Kenji M Cunnion
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 8.  Bacterial Toxins as Pathogen Weapons Against Phagocytes.

Authors:  Ana do Vale; Didier Cabanes; Sandra Sousa
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

Review 9.  Novel Evasion Mechanisms of the Classical Complement Pathway.

Authors:  Brandon L Garcia; Seline A Zwarthoff; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2016-09-15       Impact factor: 5.422

10.  Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement.

Authors:  Henry A Choy
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.